Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fosamax Plus D in Osteoporosis
NCT00092066Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Sep 2003
- Primary completion
- May 2004
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
01
Overview
Phase 3, randomised, double-blind trial of alendronate + cholecalciferol in osteoporosis (2 arms), sponsored by Organon & Co. Primary endpoint: Proportion of patients with Vitamin D insufficiency at 15 weeks. Started Sep 2003; status: completed.
02
Drugs
alendronate + cholecalciferol
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00092066.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00092066.